Wire · opportunities
Men battling baldness may soon have a new pill to turn to
◆ Sectors
Health
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 25 October 2026 · Fusion42 review
An extended-release oral version of minoxidil, developed by Veradermics, has shown positive phase 3 trial results in regrowing hair for men with pattern baldness and may become the first new FDA-approved oral treatment in nearly 30 years.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You have a rare chance to enter a market with the first new oral hair-loss pill in decades. Start exploring partnerships or product development as competition is about to ramp up.
◆ Coverage
1 source · 25 Oct 2026
◆ Related on Wire
◆ Topics
Healthhair-lossoral-treatmentminoxidilclinical-trialbiopharma